EP3585442
THERAPY OF SMALL-CELL LUNG CANCER (SCLC) WITH A TOPOISOMERASE-I INHIBITING ANTIBODY-DRUG CONJUGATE (ADC) TARGETING TROP-2
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.2.2018EP published:
11.10.2023EP application number:
18758120.2
EPO information:
European Patent Register
Max expiry date:
20.2.2038
Title in English:
THERAPY OF SMALL-CELL LUNG CANCER (SCLC) WITH A TOPOISOMERASE-I INHIBITING ANTIBODY-DRUG CONJUGATE (ADC) TARGETING TROP-2Language of the patent:
English
Timeline
Today
21.2.2018EP application
11.10.2023EP Publication
Owner
Name:
Immunomedics, Inc.Address:
300 American Road, Morris Plains, NJ 07950, US
Inventor
Name:
GOLDENBERG, David M.Address:
Morris Plains, New Jersey 07950, US
Name:
GOVINDAN, Serengulam V.Address:
Morris Plains, New Jersey 07950, US
Priority
Number:
201762463316 PDate:
24.2.2017Country:
US
Number:
201715820708Date:
22.11.2017Country:
US
Classification
Categories:
A61K 47/68, A61K 31/33, C07K 16/30, A61K 31/137, A61K 31/138, A61K 31/255, A61K 31/407, A61K 31/4184, A61K 31/198, A61K 31/513, A61K 31/555, A61K 31/7068, A61K 31/4535, A61K 31/517